DeCode Genetics has appointed Axel Nielson to be chief operating officer until the company’s next annual meeting of its board of directors, the company stated in an SEC filing this week. Nielson has worked in several positions at Decode, including chief financial officer, VP of finance, treasurer, VP of investor relations, COO of US operations, and VP of operations.
Chip Leveille, Mark Solakian, Jan Groen, Axel Nielson
Chip Leveille has been appointed vice president of sales and marketing and Mark Solakian has been named vice president and general counsel at Helicos Bioscience, the company said this week.
Leveille previously served for six years at Affymetrix where he served as vice president in three separate capacities – pharmaceutical business, core technologies group, and corporate marketing.
Solakian is also an Affy alumn. He most recently served as vice president and chief corporate counsel for Affymetrix. Prior to joining Affy, Solakian was an attorney at Goodwin Procter in Boston. He holds an AB from Harvard College and a JD from Boston College Law School.
Agendia has named Jan Groen to the post of chief operating officer. Groen previously was VP of research and development at Focus Diagnostics, and he was co-founder and R&D director at ViroClinics. Groen also was a virologist at the Erasmus Medical Center in Rotterdam and had worked at the management level at the National Institute of Public Health and Environmental Protection in the Netherlands.